Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

Aksu, Tolga; Güler, Tümer Erdem; Yalın, Kıvanç; Gölcük, Şükriye Ebru; Özcan, Kazım Serhan

Journal Metrics

Impact Factor (2024): 0.9
CiteScore (2023): 1.3
Source Normalized Impact
per Paper:
0.315
SCImago Journal Rank: 0.250

52/8Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2017; 45(1): 67-72 | DOI: 10.5543/tkda.2016.43569

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

Tolga Aksu¹, Tümer Erdem Güler¹, Kıvanç Yalın², Şükriye Ebru Gölcük², Kazım Serhan Özcan¹
¹Kocaeli Derince Education and Research Hospital, Department of Cardiology, Kocaeli, Turkey
²Bayrampasa Kolan Hospital, Department of Cardiology, Istanbul, Turkey

Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable alternative treatment for patients with suitable anatomy. Endocardial septal ablation (ESA) therapy is a little-known method of SRT. Presently described is case of successful ESA procedure performed for HOCM.

Keywords: Ablation, alcohol septal ablation, hypertrophic obstructive cardiomyopathy, radiofrequency, septal myectomy.

Corresponding Author: Tolga Aksu, Türkiye
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar